Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Enrolling by invitation × Gemcitabine × Clear all

Phase

Status

Completed 254 Terminated 80 Recruiting 32 Active not recruiting 28 Unknown 24 Withdrawn 15 Not yet recruiting 3 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphatic Metastasis 1

Interventions

toripalimab 1 tislelizumab 1 pembrolizumab 1 ibrutinib 1 fludarabine 1 Spinal Puncture 1 Propranolol 1 Positron-Emission Tomography 1 Nivolumab 1 Magnetic Resonance Imaging 1 JNJ-64619178 1 JNJ-64264681 1 Gemcitabine 1 Dexamethasone 1 Deoxycholic Acid 1 Cyclophosphamide 1 Cisplatin 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07353294 2026-04-22

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1 Enrolling by invitation

Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡